Concepedia

M.C. Mir

MM

4

Publications

121

Citations

4

H-Index

2014

Active since

Affiliations

University of Virginia(Current)

Fundación Instituto Valenciano de Oncología

Cleveland Clinic

M.C. Mir is an author at University of Virginia specializing in oncology, urology, and medicine.

Top concepts

Publications per year

2014–2022

4

Publications

4

CD117+ cells in the circulation are predictive of advanced prostate cancer

Bethany A. Kerr, Ranko Miocinovic, Armine K. Smith et al. · Oncotarget · 2014 · 52 citations · Full text

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer

Haris Zahoor, M.C. Mir, Pedro C. Barata et al. · Investigational New Drugs · 2019 · 38 citations

, , +8

External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis

Selçuk Erdem, Umberto Capitanio, Riccardo Campi et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 16 citations

, , +9

Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer

Vadim S. Koshkin, M.C. Mir, Pedro C. Barata et al. · Investigational New Drugs · 2019 · 15 citations

, , +9

Rows per page

1–4 of 4